Reconsidering the overuse of short-acting β(2)-agonists: clinical relevance beyond symptom relief

Overuse of short-acting β(2)-agonists in asthma may reflect a pattern of persistent eosinophilic inflammation, highlighting the need for individualised assessment and treatment strategies based on inflammatory markers and patient-reported inhaler use https://bit.ly/3H8rB0z.